ENVISAGENICS - Key Persons


Adrian Krainer

Job Titles:
  • Member of the Scientific and Business Advisory Board
  • Professor & Program Chair / Cancer Center Deputy Director of Research Cold Spring Harbor Laboratory

Dr. Martin Akerman - CTO, Founder

Job Titles:
  • Co - Founder
  • CTO
  • Member of the Board
Dr. Martin Akerman is the inventor of SpliceCore®, Envisagenics' flagship platform born of his vision of applying machine learning to RNA information and discovering new drug targets in areas of unmet need. Martin trained as a postdoctoral fellow with Dr. Adrian Krainer at Cold Spring Harbor Laboratory, where he helped in the development of Spinraza®, the first FDA-approved RNA therapeutic for treating Spinal Muscular Atrophy. Dr. Akerman received his PhD in Bioinformatics from Technion, Israel Institute of Technology, where he studied how RNA splicing can boost functionality of the human genome and trigger diseases.

Edward P. Evans

Job Titles:
  • Chairman in MDS, Director, Memorial Sloan Kettering Center for Hematologic Malignancies

Grant Verstandig

Job Titles:
  • Co - Founder, Red Cell Partners / Founder, Rally Health

Idera Pharmaceuticals

Job Titles:
  • Visiting Professor / University of Massachusetts Medical School

Maria Luisa Pineda - CEO, Founder

Job Titles:
  • CEO
  • Co - Founder
  • Member of the Board
Dr. Maria Luisa Pineda started as a high school Intel International Science Fair winner. For her undergraduate studies, Dr. Pineda was awarded an endowment of $2 million dollars from the Goizueta Foundation and an NIH fellowship with the Minority Access to Research Careers (MARC U*STAR) program. Dr. Pineda received her Doctorate from the prestigious Cold Spring Harbor Laboratory School of Biological Sciences as an Arnold and Mabel Beckman graduate student and a William Randolph Hearst foundation scholar. After graduating, she acquired investment experience in technology and life-sciences startup companies at Canrock Ventures and Golden Seeds, LLC. Under her leadership, Envisagenics has received non-dilutive SBIR grants from the National Institutes of Health, raised capital from investors, won several prestigious artificial intelligence competitions, and formed multiple research collaboration partnerships with Biopharma.

Michael Grissinger

Job Titles:
  • Member of the Board
  • Executive BD, Johnson & Johnson

Michael Q Zhang

Job Titles:
  • Member of the Scientific and Business Advisory Board
  • Professor & Director

Sudhir Agrawal

Job Titles:
  • Founding Scientist